Prevalence of the metabolic syndrome in individuals with hyperuricemia in central Taiwan

Journal of Internal Medicine of Taiwan

Volumn 19, Issue 4, 2008, Pages 325-330

  Tsai, Dong Hwa ^a   Lin, Shi Dou ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Hyperuricemia; Metabolic syndrome; NCEP ATP III

Indexed keywords

URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NORMAL VALUE; PATIENT SELECTION; PREVALENCE; RISK ASSESSMENT; TAIWAN;

EID: 52249118520     PISSN: 10167390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004; 25: 4-9.
2. Chou P, Soong LN. Community-based epidermiologic study on hyperuricemia in Pu-Li, Taiwan. J Formos Med Assoc 1993; 92: 597-602.
3. Lin KC, Lin HY, Chou P. Community based epidermiologic study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000; 27: 1045-50.
4. Onat A, Uyarel H, Hergenç G, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19: 1055-62.
5. Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int Obes Relat Metab Disord 1996; 20: 975-80.
6. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995; 142: 288-94.
7. Emmerson B. Hyperlipidemia in hyperuricemia and gout. Ann Rheum Dis 1998; 57: 509-10.
8. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 2001; 19: 1209-15.
9. Third report of the National Cholesterol Education Program (N-CEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-421.
10. Jermendy G, Hetyesi K, Biro L, et al. Prevalence of the metabolic syndrome in hypertensive and/or obese subjects. Diabet Med 2004; 21: 805-6.
11. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120: 442-7.
12. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4:1-9.
13. Nakanishi N, Suzuki K, Kawashimo H, Nakamura K, Tatara K. Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol 1999; 9: 99-106.
14. Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men: role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 20: 975-80.
15. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131: 1017-27.
16. Golembiewska E, Ciechanowski K, Safranow K, Kedzierska K, Kabat-Koperska J. Renal handling of uric acid in patients with type 1 diabetes in relation to glycemic control. Arch Med Res 2005; 36: 32-5.
17. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266: 3008-11.
18. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
19. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25: 39-42.
20. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 2002; 25: 1790-4.
21. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
22. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385-90.
23. Solymoss BC, Bourassa MG, Campeau L, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93: 159-64.
24. Desai MY, Santos RD, Dalta D, at al. Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am J cardiol 2005; 95: 865-8.
25. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Neito FJ. Correltaes of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996; 6: 331-40.
26. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular diaease and death: The Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
27. Moriarity JT, Folsom AR, Iribanen C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000; 10: 136-43.
28. Yoo TW, Sung KC, Shin HS, et al. Relationship between serun uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-33.
29. Sumino H, Ichikawa S, Kanda T, et al. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricemia. Lancet 1999; 354: 650.
30. Wingrove CS, Walton C, Stevenson JC. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism 1998; 47: 435-8.
31. Denzer C, Muche R, Mayer H, Heinze E, Debatin KM, Wabitsch M. Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. J Pediatr Endocrino Metab 2003; 16: 1225-32.
32. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
33. Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis 2007; 191: 305-12.
34. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007; 7: 220.